SCHEMBL25833583

SCHEMBL25833583

CNCc1ncc(-c2ccc(F)cc2)[nH]1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.47
SSTR3 P32745 1/20 0.44
SCN10A Q9Y5Y9 5/20 0.42
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SCN5A Q14524 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20221254 0.90 PDE10A (0.47) PDE10ASCN10ASCN5A
SCHEMBL17790219 0.83 PDE10A (0.60) PDE10A
SCHEMBL19390585 0.83 PDE10A (0.49) PDE10ASCN10ASCN5AALDH1A1MAPT
SCHEMBL2163489 0.76 BACE1 (0.44) PDE10ASSTR3CCNB2CDK1CCNB1
Hydrochloric Acid SCHEMBL28446503 0.75 SCN10A (0.44) PDE10ASCN10ASCN5A
SCHEMBL5756074 0.73 SCN2A (0.49) PDE10ASSTR3SCN10ACCNB2CDK1
SCHEMBL8221175 0.73 MASP2 (0.66) PDE10ACCNB2CDK1CCNB1GSK3A
SCHEMBL7483325 0.73 CYP2A6 (0.53) PDE10ASSTR3CCNB2CDK1CCNB1
SCHEMBL17516278 0.72 ALDH1A1 (0.42) PDE10ASSTR3CCNB2CDK1CCNB1
SCHEMBL19789920 0.72 SSTR3 (0.42) PDE10ASSTR3SCN10ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023135057-A1 BICYCLIC TRIAZINE DERIVATIVES FOR THE TREATMENT OF CANCER DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2023-07-20 WO disclosed